Open AccessDonor cell‐derived chronic myelomonocytic leukemia presenting after allogeneic hematopoietic cell transplantation for T‐cell acute lymphoblastic leukemia
Author(s) -
Miller Kevin C.,
Abdel Rahman Zaid H.,
Robetorye Ryan S.,
Foran James M.
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3383
Subject(s) - medicine , chronic myelomonocytic leukemia , hematopoietic stem cell transplantation , transplantation , leukemia , hematopoietic cell , lymphoblastic leukemia , juvenile myelomonocytic leukemia , immunology , haematopoiesis , cancer research , stem cell , bone marrow , myelodysplastic syndromes , biology , genetics
Donor cell leukemia is a very rare cause of relapse after allogeneic hematopoietic cell transplantation (alloHCT). Herein, we describe an unprecedented case of donor cell‐derived chronic myelomonocytic leukemia (CMML) presenting seven years after a 51‐year‐old man received a matched‐related alloHCT from his 59‐year‐old brother for T‐cell acute lymphoblastic leukemia.